181 related articles for article (PubMed ID: 38560566)
1. GRIK1 promotes glioblastoma malignancy and is a novel prognostic factor of poor prognosis.
Hou G; Xu X; Hu W
Oncol Res; 2024; 32(4):727-736. PubMed ID: 38560566
[TBL] [Abstract][Full Text] [Related]
2. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
3. Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.
Martins EP; Gonçalves CS; Pojo M; Carvalho R; Ribeiro AS; Miranda-Gonçalves V; Taipa R; Pardal F; Pinto AA; Custódia C; Faria CC; Baltazar F; Sousa N; Paredes J; Costa BM
Mol Oncol; 2022 Jul; 16(14):2611-2631. PubMed ID: 34919784
[TBL] [Abstract][Full Text] [Related]
4. CHRM3 is a novel prognostic factor of poor prognosis and promotes glioblastoma progression via activation of oncogenic invasive growth factors.
Zhang B; Zhao J; Wang Y; Xu H; Gao BO; Zhang G; Han B; Song G; Zhang J; Meng W
Oncol Res; 2023; 31(6):917-927. PubMed ID: 37744266
[TBL] [Abstract][Full Text] [Related]
5. lncRNA KTN1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑505‑3p.
Mu Y; Tang Q; Feng H; Zhu L; Wang Y
Oncol Rep; 2020 Dec; 44(6):2645-2655. PubMed ID: 33125151
[TBL] [Abstract][Full Text] [Related]
6. Nuclear respiratory factor 1 transcriptomic signatures as prognostic indicators of recurring aggressive mesenchymal glioblastoma and resistance to therapy in White American females.
Bhawe K; Das JK; Yoo C; Felty Q; Gong Z; Deoraj A; Liuzzi JP; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Komotar RJ; Roy D
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1641-1682. PubMed ID: 35441887
[TBL] [Abstract][Full Text] [Related]
7. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
8. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
[TBL] [Abstract][Full Text] [Related]
9. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
10. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma.
Li Y; Liu X; Zhao F; Zhao Z; Li X; Wang J; Huang B; Chen A
CNS Neurosci Ther; 2024 Feb; 30(2):e14366. PubMed ID: 37485655
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Verma BK; Chickabasaviah YT; Arivazhagan A; Kondaiah P; Santosh V
J Neurooncol; 2021 Mar; 152(1):55-65. PubMed ID: 33389566
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.
Safaee M; Clark AJ; Oh MC; Ivan ME; Bloch O; Kaur G; Sun MZ; Kim JM; Oh T; Berger MS; Parsa AT
PLoS One; 2013; 8(4):e62765. PubMed ID: 23658650
[TBL] [Abstract][Full Text] [Related]
14. STAT6 expression in glioblastoma promotes invasive growth.
Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
16. circFLNA promotes glioblastoma proliferation and invasion by negatively regulating miR‑199‑3p expression.
Sun Y; Ma G; Xiang H; Wang X; Wang H; Zhang Y; Qie F; Li C
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498720
[TBL] [Abstract][Full Text] [Related]
17. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
18. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
[TBL] [Abstract][Full Text] [Related]
19. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
20. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
